Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome

Fertility and Sterility

Volumn 75, Issue 2, 2001, Pages 332-336

  Strehler, Erwin ^a   Abt, Markus ^b   El Danasouri, Imam ^a   De Santo, Mariella ^c   Sterzik, Karl ^a  

^a Institute for Reproductive Medicine   (Germany)

^b UNIVERSITY OF AUGSBURG   (Germany)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Generalized linear model; hMG; ICSI; IVF; Recombinant FSH

Indexed keywords

HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY; MENOTROPINS; PREGNANCY; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SPERM INJECTIONS, INTRACYTOPLASMIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035139996     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(00)01696-4     Document Type: Article

References (14)

1. Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase
2. The role of luteinizing hormone in folliculogenesis and ovulation induction
3. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles; a meta-analysis
4. The effect of human menopausal gonadotropin and highly purified, urine derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women
5. Simplification of IVF; minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction
6. Aggressive sperm immobilization prior to intracytoplasmic sperm injection with immature spermatozoa improves fertilization and pregnancy rates
7. An 18-month survey of infertility treatment by in vitro fertilization, gamete and zygote intrafallopian transfer, and replacement of frozen-thawed embryos
8. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization outcome
9. A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients
10. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome
11. Blastocyst culture and transfer; analysis of results and parameters affecting outcome in two in vitro fertilization programs
12. Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles; a meta-analysis